212 related articles for article (PubMed ID: 33442399)
1. Multiple microarray analyses identify key genes associated with the development of Non-Small Cell Lung Cancer from Chronic Obstructive Pulmonary Disease.
Zhang L; Chen J; Yang H; Pan C; Li H; Luo Y; Cheng T
J Cancer; 2021; 12(4):996-1010. PubMed ID: 33442399
[No Abstract] [Full Text] [Related]
2. Identification of genes and pathways leading to poor prognosis of non-small cell lung cancer using integrated bioinformatics analysis.
Cui S; Lou S; Feng J; Tang X; Xiao X; Huang R; Guo W; Zhou Y; Huang F
Transl Cancer Res; 2022 Apr; 11(4):710-724. PubMed ID: 35571642
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome Analysis Revealed a Highly Connected Gene Module Associated With Cirrhosis to Hepatocellular Carcinoma Development.
Shan S; Chen W; Jia JD
Front Genet; 2019; 10():305. PubMed ID: 31001331
[TBL] [Abstract][Full Text] [Related]
4. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
5. Investigation of key miRNAs and potential mechanisms in non-small cell lung cancer development from chronic obstructive pulmonary disease.
Denkçeken T; Pala E
Gen Physiol Biophys; 2020 Jan; 39(1):69-77. PubMed ID: 32039826
[TBL] [Abstract][Full Text] [Related]
6. Identification of dynamic signatures associated with smoking-related squamous cell lung cancer and chronic obstructive pulmonary disease.
Sun X; Shang J; Wu A; Xia J; Xu F
J Cell Mol Med; 2020 Jan; 24(2):1614-1625. PubMed ID: 31829519
[TBL] [Abstract][Full Text] [Related]
7. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
Yu Y; Tian X
Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of key genes associated with non-small-cell lung cancer.
Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
[TBL] [Abstract][Full Text] [Related]
10. Identification of key differentially expressed mRNAs and microRNAs in non-small cell lung cancer using bioinformatics analysis.
Wang W; Wang S; Pan L
Exp Ther Med; 2020 Oct; 20(4):3720-3732. PubMed ID: 32855723
[TBL] [Abstract][Full Text] [Related]
11. Identification of Susceptible Genes for Chronic Obstructive Pulmonary Disease with Lung Adenocarcinoma by Weighted Gene Co-Expression Network Analysis.
Li P; Wang Y; Wang X; Liu L; Chen L
Onco Targets Ther; 2021; 14():3625-3634. PubMed ID: 34113128
[TBL] [Abstract][Full Text] [Related]
12. Identification of key candidate tumor biomarkers in non-small-cell lung cancer by
Chen W; Zhu S; Zhang Y; Xiao J; Tian D
Oncol Lett; 2020 Jan; 19(1):1008-1016. PubMed ID: 31897214
[TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of Prognostic Markers for Lung Squamous Cell Carcinoma Associated with Chronic Obstructive Pulmonary Disease.
Li Z; Xu D; Jing J; Wang J; Jiang M; Li F
J Oncol; 2022; 2022():4254195. PubMed ID: 36035311
[TBL] [Abstract][Full Text] [Related]
14. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
15. Identification of Survival-Associated Gene Signature in Lung Cancer Coexisting With COPD.
Miao TW; Du LY; Xiao W; Mao B; Wang Y; Fu JJ
Front Oncol; 2021; 11():600243. PubMed ID: 33791201
[No Abstract] [Full Text] [Related]
16. Identification of potential therapeutic target genes and mechanisms in non-small-cell lung carcinoma in non-smoking women based on bioinformatics analysis.
Zhou W; Yin M; Cui H; Wang N; Zhao LL; Yuan LZ; Yang XP; Ding XM; Men FZ; Ma X; Na JR
Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3375-84. PubMed ID: 26439031
[TBL] [Abstract][Full Text] [Related]
17. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms.
Selvaraj G; Kaliamurthi S; Kaushik AC; Khan A; Wei YK; Cho WC; Gu K; Wei DQ
J Biomed Inform; 2018 Oct; 86():120-134. PubMed ID: 30195659
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
19. Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical Carcinoma.
Xu WH; Wu J; Wang J; Wan FN; Wang HK; Cao DL; Qu YY; Zhang HL; Ye DW
Front Genet; 2019; 10():821. PubMed ID: 31572440
[No Abstract] [Full Text] [Related]
20. Exploration of estrogen receptor-associated hub genes and potential molecular mechanisms in non-smoking females with lung adenocarcinoma using integrated bioinformatics analysis.
Wang H; Zhang Z; Xu K; Wei S; Li L; Wang L
Oncol Lett; 2019 Nov; 18(5):4605-4612. PubMed ID: 31611968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
